Talon, you just discovered why our Parkison's trial was delayed!
Talon: "...the "Shake it Up" organization in Australia has just announced Duke University's research into a blood centered biomarker for Parkinson's. Researchers have discovered that in people who have Parkinson's there is damage within their brain mitochondria. Just like Alzheimer's the S1 repair mechanism should show up in people who take 2-73. The MJFF working thru "Shake it up Australia" is conducting a test prior to further trials where this biomarker should show that 2-73 is repairing the mitochondria."